Physician

Mark J Rivellese, M.D.

According to 2025 Medicare claims, Mark Rivellese, M.D. (NPI: 1891798039) practices ophthalmology in the Atlanta-Sandy Springs-Roswell, GA market, with the plurality of this provider's patient population coming from De Kalb, GA. This provider's primary affiliated billing organization is GEORGIA RETINA, PC (NPI: 1023027430; TIN: 581519372) and primary practice location at 30084-6932. Rivellese is affiliated with the Emory Healthcare Network Advantage (ACO ID: A4771) and VillageMD Primary Providers ACO V, LLC (ACO ID: D0105), participating under both the MSSP and REACH models.

Rivellese's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 931 traditional Medicare patients, billed 48,769 HCPCS/CPT codes, and received $2,403,792 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 742 prescription claims across 220 beneficiaries totaling $53,002 in drug costs, led by Bromfenac Sodium (Bromfenac Sodium). Open Payments data shows 29 records totaling $1,596. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,696,362 to $2,403,792. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.